| Jacqueline Lee Landers, MSW LCSW CSAC | |
|
15460 W Capitol Dr Ste 222, Brookfield, WI 53005-2632 | |
| (262) 408-0588 | |
| (262) 373-0362 |
| Full Name | Jacqueline Lee Landers |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 27 Years |
| Location | 15460 W Capitol Dr Ste 222, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043303787 | NPI | - | NPPES |
| 40922200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 11947 (Wisconsin) | Secondary |
| 1041C0700X | Social Worker - Clinical | 6864-123 (Wisconsin) | Primary |
| Entity Name | Landers Psychotherapy Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851786529 PECOS PAC ID: 4082934468 Enrollment ID: O20150527000461 |
News Archive
Findacure, a rare diseases charity based in Cambridge, saysrepurposing existing drugs to treat rare diseases will improve patient outcomes and save the NHS money.
The study, which appeared on the pre-print server medRxiv, presented mortality rates and case-fatality rates for COVID-19 compared with other historic leading causes of death in the United States.
Patients and researchers will be able to look at data on the safety of different medicines announced Health Minister, Lord Warner today. The move is part of a series of measures to further improve the drug side effect reporting system - the Yellow Card Scheme, which is used by the medicines watchdog (MHRA) to monitor the safety of medicines in the UK.
Imagine having your health care information at your fingertips, in one convenient place. No more surfing the Internet to find reliable, personalized, information. Independence Blue Cross (IBC) announces the launch of an enhanced member website at www.ibxpress.com, which offers one convenient source for members' health care needs.
Ranbaxy Laboratories Limited announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Antara Capsules, 43 and 130 mg, respectively, of Lupin Atlantis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Lee Landers, MSW LCSW CSAC 15460 W Capitol Dr Ste 222, Brookfield, WI 53005-2632 Ph: (262) 408-0588 | Jacqueline Lee Landers, MSW LCSW CSAC 15460 W Capitol Dr Ste 222, Brookfield, WI 53005-2632 Ph: (262) 408-0588 |
News Archive
Findacure, a rare diseases charity based in Cambridge, saysrepurposing existing drugs to treat rare diseases will improve patient outcomes and save the NHS money.
The study, which appeared on the pre-print server medRxiv, presented mortality rates and case-fatality rates for COVID-19 compared with other historic leading causes of death in the United States.
Patients and researchers will be able to look at data on the safety of different medicines announced Health Minister, Lord Warner today. The move is part of a series of measures to further improve the drug side effect reporting system - the Yellow Card Scheme, which is used by the medicines watchdog (MHRA) to monitor the safety of medicines in the UK.
Imagine having your health care information at your fingertips, in one convenient place. No more surfing the Internet to find reliable, personalized, information. Independence Blue Cross (IBC) announces the launch of an enhanced member website at www.ibxpress.com, which offers one convenient source for members' health care needs.
Ranbaxy Laboratories Limited announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Antara Capsules, 43 and 130 mg, respectively, of Lupin Atlantis.
› Verified 1 days ago